Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 174
Filter
1.
Sci Rep ; 11(1): 16152, 2021 08 09.
Article in English | MEDLINE | ID: mdl-34373551

ABSTRACT

Chemical communication via pheromones is an integral component in insect behavior, particularly for mate searching and reproduction. Aggregation pheromones, that attract conspecifics of both sexes, are particularly common and have been identified for hundreds of species. These pheromones are among the most ecologically selective pest suppression agents. In this study, we identified an activating effect of the aggregation pheromone of the red flour beetle, Tribolium castaneum (Herbst) (Coleoptera: Tenibroidae) on a highly conserved circadian clock gene (Tctimeless). Tribolium castaneum is one of the most damaging cosmopolitan pest of flour and other stored food products. Its male produced aggregation pheromone, 4,8-dimethyldecanal (DMD), attracts both conspecific males and females and is used for pest management via monitoring and mating disruption. The Tctimeless gene is an essential component for daily expression patterns of the circadian clock and plays vital roles in eclosion, egg production, and embryonic development. In this study, we demonstrate that constant exposure to the species-specific aggregation pheromone led to Tctimeless up-regulation and a different pattern of rhythmic locomotive behavior. We propose that changing the well-adapted "alarm clock", using DMD is liable to reduce fitness and can be highly useful for pest management.


Subject(s)
Circadian Clocks/genetics , Genes, Insect , Tribolium/genetics , Tribolium/physiology , Aldehydes/administration & dosage , Aldehydes/metabolism , Animals , Circadian Clocks/drug effects , Circadian Clocks/physiology , Female , Gene Expression Profiling , Genes, Insect/drug effects , Insect Control , Insect Proteins/genetics , Insect Proteins/physiology , Male , Period Circadian Proteins/genetics , Period Circadian Proteins/physiology , Pheromones/administration & dosage , Pheromones/physiology , Reproduction/drug effects , Reproduction/genetics , Reproduction/physiology , Social Behavior , Tribolium/drug effects
2.
Nutrients ; 13(5)2021 May 18.
Article in English | MEDLINE | ID: mdl-34069842

ABSTRACT

Alzheimer's disease (AD) is a complex progressive neurodegenerative disorder affecting humans mainly through the deposition of Aß-amyloid (Aß) fibrils and accumulation of neurofibrillary tangles in the brain. Currently available AD treatments only exhibit symptomatic relief but do not generally intervene with the amyloid and tau pathologies. The extra-virgin olive oil (EVOO) monophenolic secoiridoid S-(-)-oleocanthal (OC) showed anti-inflammatory activity through COX system inhibition with potency comparable to the standard non-steroidal anti-inflammatory drug (NSAID) like ibuprofen. OC also showed positive in vitro, in vivo, and clinical therapeutic effects against cardiovascular diseases, many malignancies, and AD. Due to its pungent, astringent, and irritant taste, OC should be formulated in acceptable dosage form before its oral use as a potential nutraceutical. The objective of this study is to develop new OC oral formulations, assess whether they maintained OC activity on the attenuation of ß-amyloid pathology in a 5xFAD mouse model upon 4-month oral dosing use. Exploration of potential OC formulations underlying molecular mechanism is also within this study scope. OC powder formulation (OC-PF) and OC-solid dispersion formulation with erythritol (OC-SD) were prepared and characterized using FT-IR spectroscopy, powder X-ray diffraction, and scanning electron microscopy (ScEM) analyses. Both formulations showed an improved OC dissolution profile. OC-PF and OC-SD improved memory deficits of 5xFAD mice in behavioral studies. OC-PF and OC-SD exhibited significant attenuation of the accumulation of Aß plaques and tau phosphorylation in the brain of 5xFAD female mice. Both formulations markedly suppressed C3AR1 (complement component 3a receptor 1) activity by targeting the downstream marker STAT3. Collectively, these results demonstrate the potential for the application of OC-PF as a prospective nutraceutical or dietary supplement to control the progression of amyloid pathogenesis associated with AD.


Subject(s)
Aldehydes/administration & dosage , Alzheimer Disease/drug therapy , Cyclopentane Monoterpenes/administration & dosage , Dietary Supplements , Olive Oil/administration & dosage , Phenols/administration & dosage , Plaque, Amyloid/drug therapy , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Animals , Brain/pathology , Disease Models, Animal , Dosage Forms , Female , Mice , Mice, Transgenic , Plaque, Amyloid/pathology , Powders , Spectroscopy, Fourier Transform Infrared
3.
Biochem Cell Biol ; 99(3): 322-329, 2021 06.
Article in English | MEDLINE | ID: mdl-34038188

ABSTRACT

This study explored the synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells by treating HNE-1 and cisplatin (diamminedichloroplatinum; DDP)-resistant HNE1/DDP nasopharyngeal cancer cell lines with DDP, autophagy inhibitors, or a combination of autophagy inhibitors and DDP. Cell viability was determined via MTT (colorimetric) and colony-forming assays, and the rate of apoptosis was determined using propidium iodide (PI) and annexin V double-staining. The expressions of proteins were determined by Western blotting. For our in-vivo studies, a murine xenograft model was established to evaluate the anti-tumor effects of the combination of autophagy inhibitor and DDP. The results showed that treatment with DDP increased the expressions of ATP-binding cassette sub-family B member 1 (ABCB1), ATP Binding Cassette Subfamily C Member 1 (ABCC1), and P-glycoprotein 1 (P-gp) in the HNE1/DDP cell lines. Treatment with chloroquine decreased the expression levels of ABCB1, ABCC1, and P-gp, and increased the formation of LC3-II and the expression levels of p62 in the HNE1/DDP cells. Additionally, the combination of autophagy inhibitors and DDP produced a synergistic effect on DDP-induced cell death and apoptosis. Furthermore, the combination of the autophagy inhibitor and DDP showed significant anti-tumor effects in the xenograft mouse model. In summary, autophagy inhibitors show synergistic anti-tumor effects with DDP in vitro against DDP-resistant nasopharyngeal cancer cells and in vivo in our xenograft murine model.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Autophagy , Drug Resistance, Neoplasm , Drug Synergism , Nasopharyngeal Carcinoma/drug therapy , Nasopharyngeal Neoplasms/drug therapy , Aldehydes/administration & dosage , Animals , Apoptosis , Cell Proliferation , Cisplatin/administration & dosage , Humans , Male , Mice , Mice, Nude , Nasopharyngeal Carcinoma/metabolism , Nasopharyngeal Carcinoma/pathology , Nasopharyngeal Neoplasms/metabolism , Nasopharyngeal Neoplasms/pathology , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
4.
Nutrients ; 13(4)2021 Apr 15.
Article in English | MEDLINE | ID: mdl-33920888

ABSTRACT

Consumption of 2,4-decadienal (2,4-DD) delays gastric emptying (GE) rate in animals. Oil heating produces 2,4-DD and other aldehydes. Here we examined whether heated oil affects GE rate and food intake in humans, and whether it is mediated by 2,4-DD. In the first experiment, 10 healthy volunteers consumed 240-g pumpkin soup with 9.2 g of heated (HO) or non-heated corn oil (CO). Subsequently, 17 participants consumed pumpkin soup containing 3.1 g of either heated corn oil (HO), 1 mg 2,4-DD + non-heated corn oil (2,4-DD), or non-heated corn oil (CO). Sixty minutes following pumpkin soup, cod roe spaghetti was provided, and then energy intake was determined. To evaluate GE rate, 13C breath test (Experiment 1) and ultrasonography (Experiments 1 and 2) were used. The results from the Experiment 1 confirmed that consumption of heated corn oil reduced GE rate. Experiment 2 showed a delayed GE rate in HO and 2,4-DD trials compared with CO trial (p < 0.05). Energy intake was approximately 600-650 kJ lower in HO and 2,4-DD trials compared with CO trial (p < 0.05). These findings suggest that 2,4-DD, either formed by oil heating or added to food, contributes to suppressing GE rate and energy intake.


Subject(s)
Aldehydes/administration & dosage , Corn Oil/administration & dosage , Energy Intake/drug effects , Gastric Emptying/drug effects , Hot Temperature , Breath Tests , Cross-Over Studies , Cucurbita , Eating/drug effects , Female , Food Additives , Healthy Volunteers , Humans , Male , Ultrasonography , Young Adult
5.
Biochem Biophys Res Commun ; 545: 27-32, 2021 03 19.
Article in English | MEDLINE | ID: mdl-33535103

ABSTRACT

Periodontitis is an inflammatory disease that affects tooth-supporting tissues. Chronic inflammation can progress to periodontitis, which results in loss of alveolar bone. Asarylaldehyde is a potential substance for bone metabolism present in natural compounds. Here, we propose the application of asarylaldehyde in the osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) to prevent bone loss. We investigated the effect of asarylaldehyde on hPDLSCs together with bone differentiation media in vitro. The osteogenic differentiation effect was observed after treatment of hPDLSCs with several concentrations of asarylaldehyde. After 21 days, osteogenic cells were identified by mineralization. We also observed that asarylaldehyde increased the mRNA expression of osteoblast-specific markers in hPDLSCs. Interestingly, asarylaldehyde regulated the levels of alkaline phosphatase (ALP) transcriptional activity through the p38/extracellular-signal-regulated kinase (ERK) signaling pathway. Notably, asarylaldehyde induced hPDLSCs to promote osteogenic differentiation. These results suggest that asarylaldehyde plays a key role in the osteogenic differentiation of hPDLSCs. Asarylaldehyde may be a good candidate for the application of natural compounds in future in periodontal regeneration.


Subject(s)
Aldehydes/pharmacology , Osteogenesis/drug effects , Periodontal Ligament/drug effects , Stem Cells/drug effects , Aldehydes/administration & dosage , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cells, Cultured , Gene Expression/drug effects , Humans , MAP Kinase Signaling System/drug effects , Osteogenesis/genetics , Osteogenesis/physiology , Periodontal Ligament/cytology , Periodontal Ligament/metabolism , Periodontitis/drug therapy , Periodontitis/pathology , Periodontitis/physiopathology , Phytotherapy , Regeneration/drug effects , Regeneration/physiology , Stem Cells/cytology , Stem Cells/metabolism
6.
Chem Res Toxicol ; 34(3): 723-732, 2021 03 15.
Article in English | MEDLINE | ID: mdl-33629582

ABSTRACT

Tobacco smoke is a complex mixture of chemicals, many of which are toxic and carcinogenic. Hazard assessments of tobacco smoke exposure have predominantly focused on either single chemical exposures or the more complex mixtures of tobacco smoke or its fractions. There are fewer studies exploring interactions between specific tobacco smoke chemicals. Aldehydes such as formaldehyde and acetaldehyde were hypothesized to enhance the carcinogenic properties of the human carcinogen, 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) through a variety of mechanisms. This hypothesis was tested in the established NNK-induced A/J mouse lung tumor model. A/J mice were exposed to NNK (intraperitoneal injection, 0, 2.5, or 7.5 µmol in saline) in the presence or absence of acetaldehyde (0 or 360 ppmv) or formaldehyde (0 or 17 ppmv) for 3 h in a nose-only inhalation chamber, and lung tumors were counted 16 weeks later. Neither aldehyde by itself induced lung tumors. However, mice receiving both NNK and acetaldehyde or formaldehyde had more adenomas with dysplasia or progression than those receiving only NNK, suggesting that aldehydes may increase the severity of NNK-induced lung adenomas. The aldehyde coexposure did not affect the levels of NNK-derived DNA adduct levels. Similar studies tested the ability of a 3 h nose-only carbon dioxide (0, 5, 10, or 15%) coexposure to influence lung adenoma formation by NNK. While carbon dioxide alone was not carcinogenic, it significantly increased the number of NNK-derived lung adenomas without affecting NNK-derived DNA damage. These studies indicate that the chemicals in tobacco smoke work together to form a potent lung carcinogenic mixture.


Subject(s)
Aldehydes/toxicity , Carbon Dioxide/toxicity , Carcinogens/toxicity , Lung Neoplasms/chemically induced , Nitrosamines/toxicity , Administration, Inhalation , Aldehydes/administration & dosage , Aldehydes/chemistry , Animals , Carbon Dioxide/administration & dosage , Carbon Dioxide/chemistry , Carcinogens/administration & dosage , Carcinogens/chemistry , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Lung Neoplasms/metabolism , Mice , Molecular Structure , Nitrosamines/administration & dosage , Nicotiana/chemistry
8.
Arterioscler Thromb Vasc Biol ; 41(1): 250-265, 2021 01.
Article in English | MEDLINE | ID: mdl-33028097

ABSTRACT

OBJECTIVE: TF (Tissue factor) plays a key role in hemostasis, but an aberrant expression of TF leads to thrombosis. The objective of the present study is to investigate the effect of 4-hydroxy-2-nonenal (HNE), the most stable and major oxidant produced in various disease conditions, on the release of TF+ microvesicles into the circulation, identify the source of TF+ microvesicles origin, and assess their effect on intravascular coagulation and inflammation. Approach and Results: C57BL/6J mice were administered with HNE intraperitoneally, and the release of TF+ microvesicles into circulation was evaluated using coagulation assays and nanoparticle tracking analysis. Various cell-specific markers were used to identify the cellular source of TF+ microvesicles. Vascular permeability was analyzed by the extravasation of Evans blue dye or fluorescein dextran. HNE administration to mice markedly increased the levels of TF+ microvesicles and thrombin generation in the circulation. HNE administration also increased the number of neutrophils in the lungs and elevated the levels of inflammatory cytokines in plasma. Administration of an anti-TF antibody blocked not only HNE-induced thrombin generation but also HNE-induced inflammation. Confocal microscopy and immunoblotting studies showed that HNE does not induce TF expression either in vascular endothelium or circulating monocytes. Microvesicles harvested from HNE-administered mice stained positively with CD248 and α-smooth muscle actin, the markers that are specific to perivascular cells. HNE was found to destabilize endothelial cell barrier integrity. CONCLUSIONS: HNE promotes the release of TF+ microvesicles from perivascular cells into the circulation. HNE-induced increased TF activity contributes to intravascular coagulation and inflammation.


Subject(s)
Aldehydes/toxicity , Cell-Derived Microparticles/drug effects , Inflammation/chemically induced , Oxidative Stress , Thromboplastin/metabolism , Thrombosis/chemically induced , Actins/metabolism , Aldehydes/administration & dosage , Animals , Antigens, CD/metabolism , Antigens, Neoplasm/metabolism , Blood Coagulation/drug effects , Cell-Derived Microparticles/metabolism , Cells, Cultured , Cytokines/blood , Female , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Inflammation/blood , Inflammation Mediators/blood , Male , Mice, Inbred C57BL , Thrombin/metabolism , Thrombosis/blood
9.
Carbohydr Polym ; 240: 116282, 2020 Jul 15.
Article in English | MEDLINE | ID: mdl-32475566

ABSTRACT

In the present study, we have demonstrated synthesis of agar aldehyde (Aald) from seaweed polysaccharide and its further successful application for preparation of Aald mediated solid silver nanocomposite (Aald-AgNPs). Aald-AgNPs were characterized for biophysical properties by FTIR, XRD, SEM, TEM, XPS, and UV-vis spectroscopy. Aald-AgNPs were further tested in vitro and in vivo for anticancer activity. The results of the in vitro study revealed that Aald-AgNPs exhibited activity against 3 cancer cell lines. Aald-AgNPs were found to act through causing dose dependent increase in cell size, inducing anueploidy, mitochondrial disintegration and increasing septa formation in cell cytoplasm. Results of in vivo anticancer activity against ME-180, Colon-26, and HL-60 xenograft mice tumor models showed 64 %, 27.3 % and 51 % reduction in tumor volume, respectively with 83-100 % survival rate. Aald-AgNPs exhibited excellent antibacterial activity. It was interesting to note that Aald-AgNPs did not exhibit any significant detrimental effect on viability and metabolic activity of normal bone marrow derived mesenchymal stem cells. This study opens new areas of research for chemists and biologists to use seaweed-derived polymers to develop nanocomposites for cancer therapeutics.


Subject(s)
Agar/administration & dosage , Aldehydes/administration & dosage , Antineoplastic Agents/administration & dosage , Biopolymers/administration & dosage , Metal Nanoparticles/administration & dosage , Nanocomposites/administration & dosage , Seaweed , Silver/administration & dosage , Animals , Anti-Bacterial Agents/administration & dosage , Cell Line, Tumor , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Humans , Mice, Inbred BALB C , Neoplasms/drug therapy
10.
Nutrients ; 12(2)2020 Jan 25.
Article in English | MEDLINE | ID: mdl-31991771

ABSTRACT

Epidemiological and clinical studies compellingly showed the ability of Mediterranean diet rich in extra-virgin olive oil (EVOO) to reduce multiple diseases such as cancer, cardiovascular diseases, and aging cognitive functions decline. The S-(-)-Oleocanthal (OC) is a minor phenolic secoiridoid exclusively found in extra-virgin olive oil (EVOO). OC recently gained notable research attention due to its excellent in vitro and in vivo biological effects against multiple cancers, inflammations, and Alzheimer's disease. However, OC safety has not been comprehensively studied yet. This study reports for the first time the detailed safety of oral single OC dose in Swiss albino mice, applying the OECD 420 procedure. Male and female Swiss albino mice (n = 10) were orally treated with a single OC dose of either 10, 250, or 500 mg/kg bodyweight or equivalent volumes of distilled water. Mice fed a regular diet, and carefully observed for 14 days. Further, mice were then sacrificed, blood samples, and organs were collected and subjected to hematological, biochemical, and histological examinations. OC 10 mg/kg oral dose appears to be without adverse effects. Further, 250 mg/kg OC, p.o., is suggested as a possible upper dose for preclinical studies in the future.


Subject(s)
Aldehydes/administration & dosage , Cyclopentane Monoterpenes/administration & dosage , Fruit , Iridoids/administration & dosage , Olea , Olive Oil , Phenols/administration & dosage , Administration, Oral , Aldehydes/isolation & purification , Aldehydes/toxicity , Animals , Cyclopentane Monoterpenes/isolation & purification , Cyclopentane Monoterpenes/toxicity , Dose-Response Relationship, Drug , Female , Fruit/chemistry , Injections, Intraperitoneal , Iridoids/isolation & purification , Iridoids/toxicity , Lethal Dose 50 , Male , Mice , Olea/chemistry , Olive Oil/chemistry , Phenols/isolation & purification , Phenols/toxicity , Risk Assessment , Time Factors , Toxicity Tests, Acute
11.
Chem Res Toxicol ; 33(3): 764-768, 2020 03 16.
Article in English | MEDLINE | ID: mdl-31989817

ABSTRACT

It is well-known that aldehydes resulting from the in vivo oxidation of primary alcohols are toxic. Here, we experimentally demonstrate in rat models that the dipeptide cysteinylglycine (CG), formed in vivo from its oxidized product, cystinyl-bis-glycine (CbG), will sequester acetaldehyde and isoamyl aldehyde, two model aldehydes resulting from the oxidation of ethanol and isoamyl alcohol, respectively, and excrete them in urine as their respective conjugation products with CG. These data suggest that a whole series of toxic aldehydes can be sequestered and detoxified by CG and may prevent the flushing syndrome exhibited by individuals with a defective enzyme that converts acetaldehyde to acetate. The data also suggest the possibility of alleviating the hangover syndrome we believe to be caused by aldehydes, such as isoamyl aldehyde derived from short, branched-chain alcohols, present as congeners in certain alcoholic beverages. The sequestration of other toxic agents, such as cyanide, that can react with CG can also be envisioned.


Subject(s)
Aldehydes/toxicity , Aldehydes/urine , Administration, Oral , Aldehydes/administration & dosage , Animals , Chromatography, High Pressure Liquid , Male , Molecular Structure , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry
12.
Free Radic Biol Med ; 145: 349-356, 2019 12.
Article in English | MEDLINE | ID: mdl-31605749

ABSTRACT

Appropriate diet is essential for the regulation of age-related macular degeneration (AMD). In particular the type of dietary polyunsaturated fatty acids (PUFA) and poor antioxidant status including carotenoid levels concomitantly contribute to AMD risk. Build-up of oxidative stress in AMD induces PUFA oxidation, and a mix of lipid oxidation products (LOPs) are generated. However, LOPs are not comprehensively evaluated in AMD. LOPs are considered biomarkers of oxidative stress but also contributes to inflammatory response. In this cross-sectional case-control study, plasma omega-6/omega-3 PUFA ratios and antioxidant status (glutathione, superoxide dismutase and catalase), and plasma and urinary LOPs (41 types) were determined to evaluate its odds-ratio in the risk of developing exudative AMD (n = 99) compared to age-gender-matched healthy controls (n = 198) in adults with Chinese diet. The odds ratio of developing exudative AMD increased with LOPs from omega-6 PUFA and decreased from those of omega-3 PUFA. These observations were associated with a high plasma omega-6/omega-3 PUFA ratio and low carotenoid levels. In short, poor PUFA and antioxidant status increased the production of omega-6 PUFA LOPs such as dihomo-isoprostane and dihomo-isofuran, and lowered omega-3 PUFA LOPs such as neuroprostanes due to the high omega-6/omega-3 PUFA ratios; they were also correlated to the risk of AMD development. These findings indicate the generation of specific LOPs is associated with the development of exudative AMD.


Subject(s)
Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-6/administration & dosage , Macular Degeneration/metabolism , Oxidative Stress/drug effects , 3-Hydroxyacyl CoA Dehydrogenases/genetics , 3-Hydroxyacyl CoA Dehydrogenases/metabolism , Acetyl-CoA C-Acyltransferase/genetics , Acetyl-CoA C-Acyltransferase/metabolism , Aged , Aldehydes/administration & dosage , Antioxidants/administration & dosage , Biomarkers/blood , Carbon-Carbon Double Bond Isomerases/genetics , Carbon-Carbon Double Bond Isomerases/metabolism , Carotenoids/metabolism , Diet/adverse effects , Enoyl-CoA Hydratase/genetics , Enoyl-CoA Hydratase/metabolism , Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-6/metabolism , Female , Humans , Isoprostanes/administration & dosage , Lipid Peroxidation/drug effects , Lipid Peroxidation/genetics , Macular Degeneration/etiology , Macular Degeneration/genetics , Macular Degeneration/pathology , Male , Middle Aged , Neuroprostanes/administration & dosage , Oxidation-Reduction/drug effects , Oxidative Stress/genetics , Racemases and Epimerases/genetics , Racemases and Epimerases/metabolism , Risk Factors
13.
Article in English | MEDLINE | ID: mdl-31585634

ABSTRACT

2,4-Decadienal (E,E-) occurs naturally in foods and is also used as a flavoring ingredient. In vivo micronucleus studies were used to evaluate the potential for 2,4-decadienal to cause genotoxic effects. Male Han Wistar rats were dosed either by intraperitoneal injection or by gavage in two independent studies. The animals (12/group) received 25, 50, or 100 mg/kg bw of 2,4-decadienal via intraperitoneal injection, or 350, 700, or 1400 mg/kg bw via gavage. Dose-dependent decreases in the percentages of peripheral blood reticulocytes were observed in both studies, indicating that the target tissue was exposed to toxic levels of 2,4-decadienal. No induction of micronuclei in the bone marrow polychromatic erythrocytes or the peripheral blood reticulocytes was observed in either study. These results, coupled with previous mutagenicity studies, support the overall conclusion that 2,4-decadienal does not present a concern for genotoxicity.


Subject(s)
Aldehydes/toxicity , Flavoring Agents/toxicity , Administration, Oral , Aldehydes/administration & dosage , Animals , Bone Marrow Cells/drug effects , Bone Marrow Cells/ultrastructure , Dose-Response Relationship, Drug , Flavoring Agents/administration & dosage , Injections, Intraperitoneal , Male , Micronucleus Tests/methods , Random Allocation , Rats , Rats, Wistar , Reticulocytes/drug effects , Reticulocytes/ultrastructure
14.
PLoS One ; 14(8): e0216024, 2019.
Article in English | MEDLINE | ID: mdl-31412041

ABSTRACT

(-)-Oleocanthal (oleocanthal) is a phenolic compound found in varying concentrations in extra virgin olive oil oleocanthal has been shown to be active physiologically, benefiting several diseased states by conferring anti-inflammatory and neuroprotective benefits. Recently, we and other groups have demonstrated its specific and selective toxicity toward cancer cells; however, the mechanism leading to cancer cell death is still disputed. The current study demonstrates that oleocanthal, as well as naturally oleocanthal-rich extra virgin olive oils, induced damage to cancer cells' lysosomes leading to cellular toxicity in vitro and in vivo. Lysosomal membrane permeabilization following oleocanthal treatment in various cell lines was assayed via three complementary methods. Additionally, we found oleocanthal treatment reduced tumor burden and extended lifespan of mice engineered to develop pancreatic neuroendocrine tumors. Finally, following-up on numerous correlative studies demonstrating consumption of olive oil reduces cancer incidence and morbidity, we observed that extra virgin olive oils naturally rich in oleocanthal sharply reduced cancer cell viability and induced lysosomal membrane permeabilization while oleocanthal-poor oils did not. Our results are especially encouraging since tumor cells often have larger and more numerous lysosomes, making them especially vulnerable to lysosomotropic agents such as oleocanthal.


Subject(s)
Aldehydes/administration & dosage , Brain Neoplasms/drug therapy , Cell Membrane Permeability/drug effects , Cyclopentane Monoterpenes/administration & dosage , Lysosomes/drug effects , Neuroectodermal Tumors, Primitive/drug therapy , Olive Oil/administration & dosage , Phenols/administration & dosage , Plant Oils/administration & dosage , Animals , Apoptosis , Brain Neoplasms/pathology , Lysosomes/metabolism , Mice , Necrosis , Neuroectodermal Tumors, Primitive/pathology , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
15.
Int J Pharm ; 569: 118596, 2019 Oct 05.
Article in English | MEDLINE | ID: mdl-31394181

ABSTRACT

Epidemiological studies have compellingly documented the ability of the Mediterranean diet rich in extra-virgin olive oil to reduce the incidence of certain malignancies, and cardiovascular diseases, and slow the Alzheimer's disease progression. S-(-)-Oleocanthal (OC) was identified as the most bioactive olive oil phenolic with documented anti-inflammatory, anticancer, and anti-Alzheimer's activities. OC consumption causes irritating sensation at the oropharynx via activation of TRPA1. Accordingly, a taste-masked formulation of OC is needed for its future use as a nutraceutical while maintaining its bioactivity and unique chemistry. Therefore, the goal of this study was to prepare a taste-masked OC solid formulation with improved dissolution and pharmacodynamic profiles, by using (+)-xylitol as an inert carrier. Xylitol was hypothesized to serve as an ideal vehicle for the preparation of OC solid dispersions due to its low melting point and sweetness. The optimized OC-(+)-xylitol solid dispersion was physically and chemically characterized and showed effective taste masking and enhanced dissolution properties. Furthermore, OC-(+)-xylitol solid dispersion maintained potent in vivo anti-breast cancer activity. It effectively suppressed the human triple negative breast cancer development, growth, and recurrence after primary tumor surgical excision in nude mice orthotopic xenograft models. Collectively, these results suggest the OC-(+)-xylitol solid dispersion formulation as a potential nutraceutical for effective control and prevention of human triple negative breast cancer.


Subject(s)
Aldehydes/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Cyclopentane Monoterpenes/administration & dosage , Mammary Neoplasms, Experimental/drug therapy , Olive Oil , Phenols/administration & dosage , Xylitol/administration & dosage , Administration, Oral , Aldehydes/chemistry , Animals , Antineoplastic Agents, Phytogenic/chemistry , Cell Line, Tumor , Cyclopentane Monoterpenes/chemistry , Female , Humans , Mice, Nude , Models, Molecular , Phenols/chemistry , Taste , Xylitol/chemistry
16.
ACS Chem Neurosci ; 10(8): 3543-3554, 2019 08 21.
Article in English | MEDLINE | ID: mdl-31244050

ABSTRACT

Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by multiple hallmarks including extracellular amyloid (Aß) plaques, neurofibrillary tangles, dysfunctional blood-brain barrier (BBB), neuroinflammation, and impaired autophagy. Thus, novel strategies that target multiple disease pathways would be essential to prevent, halt, or treat the disease. A growing body of evidence including our studies supports a protective effect of oleocanthal (OC) and extra-virgin olive oil (EVOO) at early AD stages before the onset of pathology. In addition, we reported previously that OC and EVOO exhibited such effect by restoring the BBB function; however, the mechanism(s) by which OC and EVOO exert such an effect and whether this effect extends to a later stage of AD remain unknown. In this work, we sought first to test the effect of OC-rich EVOO consumption at an advanced stage of the disease in TgSwDI mice, an AD mouse model, starting at the age of 6 months for 3 months treatment, and then to elucidate the mechanism(s) by which OC-rich EVOO exerts the observed beneficial effect. Overall findings demonstrated that OC-rich EVOO restored the BBB function and reduced AD-associated pathology by reducing neuroinflammation through inhibition of NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome and inducing autophagy through activation of AMP-activated protein kinase (AMPK)/Unc-51-like autophagy activating kinase 1 (ULK1) pathway. Thus, diet supplementation with OC-rich EVOO could provide beneficial effect to slow or halt the progression of AD.


Subject(s)
Aldehydes/administration & dosage , Autophagy/drug effects , Blood-Brain Barrier/drug effects , Cyclopentane Monoterpenes/administration & dosage , Inflammasomes/antagonists & inhibitors , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Neuroprotective Agents/administration & dosage , Olive Oil/administration & dosage , Phenols/administration & dosage , Administration, Oral , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Animals , Blood-Brain Barrier/metabolism , Brain/drug effects , Brain/metabolism , Disease Models, Animal , Mice , Mice, Transgenic
17.
Food Funct ; 10(5): 2871-2880, 2019 May 22.
Article in English | MEDLINE | ID: mdl-31070214

ABSTRACT

4-Hydroxynonenal (HNE) is a highly reactive end-product of lipid peroxidation reaction that leads to retinal pigment epithelial (RPE) cell damage. Cyanidin-3-glucoside (C3G), the most abundant anthocyanin in the edible parts of plants, is a nutritional supplement used for preventing retinal damage. However, the protective effect of C3G against HNE-induced RPE cell damage remains to be elucidated. The protective mechanisms of C3G on ARPE-19 cells after HNE exposure were investigated in this study. Results showed that compared with HNE-treated cells, the viability of ARPE-19 cells was significantly (P < 0.05) increased after 1 and 5 µM C3G treatment. C3G exhibited a significant (P < 0.05) inhibitory effect on the expression of senescence-associated ß-galactosidase in ARPE-19 cells. VEGF levels in the C3G groups were significantly (P < 0.05) decreased relative to those of the HNE-treated group. C3G also regulated the release of two inflammatory mediators, namely monocyte chemoattractant protein 1 and interleukine-8, in ARPE-19 cells after HNE treatment. Furthermore, C3G attenuated retinal cell apoptosis in pigmented rabbits induced by visible light. Therefore, our data showed that C3G has efficient protective effects on HNE-induced apoptosis, angiogenesis, and dysregulated cytokine production in ARPE-19 cells.


Subject(s)
Aldehydes/administration & dosage , Anthocyanins/pharmacology , Glucosides/pharmacology , Light/adverse effects , Retinal Diseases/drug therapy , Animals , Apoptosis/drug effects , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Humans , Interleukin-8/genetics , Interleukin-8/metabolism , Rabbits , Retinal Diseases/etiology , Retinal Diseases/physiopathology , Retinal Pigment Epithelium/cytology , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/metabolism , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
18.
Nutrients ; 11(2)2019 Feb 15.
Article in English | MEDLINE | ID: mdl-30781364

ABSTRACT

Dysregulation of epidermal growth factor receptor (EGFR)/human epidermal growth factor-2 (HER2) family is a hallmark of aggressive breast cancer. Small-molecule tyrosine kinase inhibitors are among the most effective cancer targeted treatments. (-)-Oleocanthal (OC) is a naturally occurring phenolic secoiridoid lead from extra-virgin olive oil with documented anti-cancer activities via targeting mesenchymal epithelial transition factor (c-Met). Dysregulation of c-Met promotes aggressiveness to breast cancer-targeted therapies. Lapatinib (LP) is an FDA-approved dual EGFR/HER2 inhibitor for HER2-amplified breast cancer. HER2-Positive tumor cells can escape targeted therapies like LP effects by overexpressing c-Met. Combined OC-LP treatment is hypothesized to be mechanistically synergistic against HER2-overexpressing breast cancer. Combined sub-effective treatments of OC-LP resulted in synergistic anti-proliferative effects against the HER2-positive BT-474 and SK-BR-3 breast cancer cell lines, compared to OC or LP monotherapy. Antibody array and Western blot analysis showed that combined OC-LP treatment significantly inhibited EGFR, HER2, and c-Met receptor activation, as well as multiple downstream signaling proteins, compared to individual OC or LP treatment. OC-LP Combination significantly inhibited invasion and migration of breast cancer cells through reduced activation of focal adhesion kinase (FAK) and paxillin. Combined treatment of OC-10 mg/kg with LP-12.5 mg/kg suppressed more than 90% of BT-474 tumor cells growth in a nude mouse xenograft model, compared to individual OC or LP treatment. Activated c-Met, EGFR, HER2, and protein kinase B (AKT) were significantly suppressed in combination-treated mice tumors, compared to OC or LP monotherapy. This study reveals the OC future potential as combination therapy to sensitize HER2-overexpressing breast cancers and significantly reduce required doses of targeted HER family therapeutics.


Subject(s)
Aldehydes/administration & dosage , Antineoplastic Agents/administration & dosage , Breast Neoplasms/drug therapy , Lapatinib/administration & dosage , Phenols/administration & dosage , Receptor, ErbB-2/drug effects , Animals , Breast Neoplasms/metabolism , Cell Line, Tumor , Cyclopentane Monoterpenes , Drug Therapy, Combination , Epithelial-Mesenchymal Transition/drug effects , ErbB Receptors/drug effects , Female , Humans , Mice , Receptor, ErbB-2/metabolism
19.
Complement Ther Med ; 42: 298-301, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30670258

ABSTRACT

OBJECTIVE: Photodynamic therapy (PDT) is an effective treatment against skin field cancerization. Its main side effect is local inflammation in the treated area. The phenolic compound oleocanthal (decarboxy methyl ligstroside aglycone), which is present in extra virgin olive oil (EVOO), has anti-inflammatory properties. The purpose of this study was to evaluate the topical efficacy of an oily fluid enriched with oleocanthal (OC) extract, in comparison with a conventional oily fluid, in reducing the degree of inflammatory reaction after conventional PDT. METHODS: Quasi-experimental pilot study, before-after with a control group, performed with a cohort of consecutive patients diagnosed with actinic keratosis/field cancerization (AK/FC) in the forehead and/or scalp, treated by PDT. The study was carried out from April 2016 to November 2017 at a speciality hospital in southern Spain. A group of 24 consecutive patients received the topical application, three times daily for one week, of an emollient oily fluid in the area treated with PDT. Subsequently, another group, of 23 consecutive patients, received the same treatment pattern with an oily fluid enriched with OC extract. The post-PDT inflammatory reaction was measured by an independent member of the hospital's dermatology department, using the following visual scale of erythema (from 0 to 4).The assessment was conducted at 30 min and at 48 h post-PDT. RESULTS: In the assessment at 48 h after treatment, the inflammation had improved more among the patients treated with OC (median: 25%, 95%CI: -5.3 to 28.5) than in the non-OC group (median: 0%; 95%CI: -45.2 to -6.2). The difference was statistically significant (p<0.01), and the Cohen's d value was 0.89 (large effect). At three months after PDT, a complete response had been obtained by 60.9% of the patients treated with OC compared to 29.2% of the non-OC group, and the difference was close to statistical significance (p=0.059). CONCLUSIONS: The topical application of an oily fluid enriched with OC extract achieved a greater reduction in post-PDT cutaneous inflammation and a better treatment response, in comparison with the application of a conventional oily fluid.


Subject(s)
Aldehydes/therapeutic use , Inflammation/drug therapy , Olea/chemistry , Phenols/therapeutic use , Photochemotherapy/adverse effects , Phytotherapy , Skin Neoplasms/therapy , Skin/drug effects , Administration, Topical , Aged , Aged, 80 and over , Aldehydes/administration & dosage , Aldehydes/pharmacology , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Cyclopentane Monoterpenes , Erythema , Face , Female , Humans , Inflammation/etiology , Male , Middle Aged , Phenols/administration & dosage , Phenols/pharmacology , Pilot Projects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Prospective Studies , Scalp , Skin/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...